Skip to main content
SpringerLink
Log in

Clinical Pharmacokinetics of Glyceryl Trinitrate Following the Use of Systemic and Topical Preparations

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Glyceryl trinitrate has been used for more than a century for the treatment of angina pectoris and, more recently, for the treatment of congestive heart failure. The introduction of transdermal delivery systems has renewed the controversy regarding the efficacy of the drug, mainly in the light of the development of tolerance.

With concentrations of the order of 1 µg/L or less, the measurement of glyceryl trinitrate in plasma is not easy: gas chromatography with electron capture detection has been used widely but recently gas chromatography-mass spectrometry has provided satisfactory results. Assay problems are most likely to be responsible for some of the unexpected results reported. Further factors which may confound the results of the study of plasma concentrations are the rapid metabolism of glyceryl trinitrate in blood in vitro, adsorption to containers and infusion sets, and the uptake and/or metabolism in vessel walls. From the intravenous infusion data, the large interindividual variability in plasma concentrations of glyceryl trinitrate is apparent. The plasma half-life is about 2 to 3 minutes; plasma clearance values reported vary from 216 to 3270 L/h, indicating extensive non-hepatic metabolism. With transdermal administration, mainly with the transdermal controlled delivery systems, plasma concentrations of glyceryl trinitrate appear to be maintained for up to 24 hours, with large interindividual variations.

Despite the ability to maintain, for example with the transdermal delivery systems, relatively constant concentrations of glyceryl trinitrate, it has not been possible to find a relationship between plasma concentrations and pharmacological or clinical effects. This is in part due to the attenuation of the effects with time; from the available data it is clear that this attenuation occurs at a pharmacodynamic level (reflex adaptation and tolerance) and not at the pharmacokinetic level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abrams J. The brief saga of transdermal nitroglycerin discs: paradise lost? American Journal of Cardiology 54: 220–224, 1984

    Article  PubMed  CAS  Google Scholar 

  • Abrams J. Transdermal nitroglycerin and nitrate tolerance. Annals of Internal Medicine 104: 424–426, 1986

    PubMed  CAS  Google Scholar 

  • Armstrong PW, Armstrong JA, Marks GS. Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure. American Journal of Cardiology 46: 670–676, 1980a

    Article  PubMed  CAS  Google Scholar 

  • Armstrong PW, Armstrong JA, Marks GS. Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation 62: 160–166, 1980b

    Article  PubMed  CAS  Google Scholar 

  • Armstrong PW, Moffat JA, Marks GS. Arterial-venous nitroglycerin gradient during intravenous infusion in man. Circulation 66: 1273–1276, 1982

    Article  PubMed  CAS  Google Scholar 

  • Armstrong PW, Watts DG, Moffat JA. Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. British Journal of Clinical Pharmacology 16: 385–390, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bashir A, Lewis MJ, Henderson AH. Pharmacokinetic studies of various preparations of glyceryl trinitrate. British Journal of Clinical Pharmacology 14: 779–784, 1982

    Article  PubMed  CAS  Google Scholar 

  • Bennett BM, Brien JF, Nakatsu K, Marks GS. Role of hemoglobin in the differential biotransformation of glyceryl trinitrate and isosorbide dinitrate by human erythrocytes. Journal of Pharmacology and Experimental Therapeutics 234: 228–232, 1985

    PubMed  CAS  Google Scholar 

  • Bennett ED, Davis AL. A haemodynamic and pharmacokinetic study to assess a new transdermal nitroglycerin preparation in normal subjects. European Journal of Clinical Pharmacology 26: 293–296, 1984

    Article  PubMed  CAS  Google Scholar 

  • Black CD. Transdermal drug delivery systems. US Pharmacist (Nov): 49–75, 1982

    Google Scholar 

  • Blumenthal HP, Fung H-L, McNiff EF, Yap SK. Plasma nitroglycerin levels after sublingual, oral and topical administration. British Journal of Clinical Pharmacology 4: 241–242, 1977

    Article  PubMed  CAS  Google Scholar 

  • Bogaert MG. Clinical pharmacokinetics of organic nitrates. Clinical Pharmacokinetics 8: 410–421, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bogaert MG, Rosseel MT. Plasma levels in man of nitroglycerin after buccal administration. Journal of Pharmacy and Pharmacology 24: 737–738, 1972

    Article  PubMed  CAS  Google Scholar 

  • Bussmann W-D, Kromm W, Reifart N, Fung H-L. Acute hemodynamic and pharmacokinetic effects of buccal nitroglycerin. In Bussmann et al. (Eds) Controlled release nitroglycerin in buccal and oral form, Advances in pharmacotherapy, Vol. 1, pp. 64–72, Karger, Basel, 1982

    Google Scholar 

  • Chien YW. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches. American Heart Journal 108: 207–216, 1984

    Article  PubMed  CAS  Google Scholar 

  • Chiou WL, Lam G, Chen M-L, Lee MG. Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration. Research Communications in Chemical Pathology and Pharmacology 32: 27–39, 1981

    PubMed  CAS  Google Scholar 

  • Chu L-C, Gale RM, Schmitt LG, Shaw JE. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment. Angiology 35: 545–552, 1984

    Article  PubMed  CAS  Google Scholar 

  • Colfer H, Stetson P, Lucchesi BR, Wagner J, Pitt B. The nitroglycerin polymer gel matrix system: a new method for administering nitroglycerin evaluated with plasma nitroglycerin levels. Journal of Cardiovascular Pharmacology 4: 521–525, 1982

    Article  PubMed  CAS  Google Scholar 

  • Cossum PA, Roberts MS. Nitroglycerin disposition in human blood. Eur. J. Clin. Pharmacol. 29: 169–175, 1985

    Article  PubMed  CAS  Google Scholar 

  • Curfman GD, Heinsimer JA, Lozner EC, Fung H-L. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective, randomized trial. Circulation 67: 276–282, 1983

    Article  PubMed  CAS  Google Scholar 

  • Curry SH, Aburawi SM. Analysis, disposition and pharmacokinetics of nitroglycerin. Biopharmaceutics and Drug Disposition 6: 235–280, 1985

    Article  CAS  Google Scholar 

  • Curry SH, Kwon H-R. Influence of posture on plasma nitroglycerin. British Journal of Clinical Pharmacology 19: 403–404, 1985

    Article  PubMed  CAS  Google Scholar 

  • Curry SH, Kwon H-R, Perrin JH, Culp JR, Pepine CJ. et al. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin. Clinical Pharmacology and Therapeutics 36: 765–772, 1984

    Article  PubMed  CAS  Google Scholar 

  • Dasta JF, Weber RJ, Wu LS, Sokoloski TD, Kakos GS, et al. Influence of cardiopulmonary bypass on nitroglycerin clearance. Journal of Clinical Pharmacology 26: 165–168, 1986

    PubMed  CAS  Google Scholar 

  • Elliott GT, Quinn SL. Nitroglycerin intravenous infusion. Drug Intelligence and Clinical Pharmacy 16: 211–217, 1982

    PubMed  CAS  Google Scholar 

  • Fung H-L. Pharmacokinetic determinants of nitrate action. American Journal of Medicine 76(6A): 22–26, 1984

    Article  PubMed  CAS  Google Scholar 

  • Fung H-L, Sutton SC, Kamiya A. Blood vessel uptake and metabolism of organic nitrates in the rat. Journal of Pharmacology and Experimental Therapeutics 228: 334–341, 1984

    PubMed  CAS  Google Scholar 

  • Gaudry D, Gérardin A, Briand C, Wantiez D. Quantitative determination of nitroglycerol in human plasma by gas chromatography negative ion mass spectrometry using 15N labeled nitroglycerol as internal standard. Biomedical Mass Spectrometry 11: 276–277, 1984

    Article  PubMed  CAS  Google Scholar 

  • Gérardin A, Gaudry D, Moppert J, Theobald W, Frankhauser P. Glycerol trinitrate (nitroglycerin) plasma concentrations achieved after application of transdermal therapeutic systems to healthy volunteers. Arzneimittel-Forschung 35: 530–532, 1985

    PubMed  Google Scholar 

  • Gielsdorf W, Schlegel E, Settlage JA, Jaeger H, Fink E. Bioverfügbarkeit von Glyceroltrinitrat (Nitroglycerin) aus einer Salbenzubereitung. Arzneimittel-Forschung 33: 1677–1679, 1983

    PubMed  CAS  Google Scholar 

  • Heidemann R, Menke G, Letzel H, Rietbrock N. Serumkonzentration von Glyceroltrinitrat (GTN) bei transdermaler Applikation von GTN-Pflastern unterschiedlicher Provenienz. Deutsche Medizinische Wochenschrift 110: 1568–1572, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hill AB, Bowley CJ, Nahrwold ML, Knight PR, Kirsh MM, et al. Intranasal administration of nitroglycerin. Anesthesiology 54: 346–348, 1981

    Article  PubMed  CAS  Google Scholar 

  • Iafrate RP, Yost RL, Curry SH, Gotz VP, Caranasos GJ. Effect of dose and ointment application technique on nitroglycerin plasma concentrations. Pharmacotherapy 3: 118–124, 1983

    PubMed  CAS  Google Scholar 

  • Imhof PR, Ott B, Frankhauser P, Chu L-C, Hodler J. Difference in nitroglycerin dose-response in the venous and arterial beds. European Journal of Clinical Pharmacology 18: 455–460, 1980

    Article  PubMed  CAS  Google Scholar 

  • Imhof PR, Sieber A, Hodler J, Müller P, Ott B, et al. Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers. European Journal of Clinical Pharmacology 23: 99–106, 1982

    Article  PubMed  CAS  Google Scholar 

  • Imhof PR, Vuillemin T, Gérardin A, Racine A, et al. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS). European Journal of Clinical Pharmacology 27: 7–12, 1984

    PubMed  CAS  Google Scholar 

  • Jordan RA, Seth L, Casebolt P, Hayes MJ, Wilen MM, et al. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. Annals of Internal Medicine 104: 295–298, 1986

    PubMed  CAS  Google Scholar 

  • Karim A. Transdermal absorption: a unique opportunity for constant delivery of nitroglycerin. Drug Development and Industrial Pharmacy 9: 671–689, 1983

    Article  CAS  Google Scholar 

  • Magometschnigg D, Horwatitsch H, Pichler M. Plasma concentration of cutaneously applied trinitroglycerin. International Journal of Clinical Pharmacology 21: 178–182, 1983

    CAS  Google Scholar 

  • Maier GA, Poliszczuk A, Fung H-L. Stability of nitroglycerin in human and rat plasma. International Journal of Pharmaceutics 4: 75–82, 1979

    Article  CAS  Google Scholar 

  • Maier-Lenz H, Ringwelski L, Windorfer A. Pharmakokinetik und relative Bioverfügbarkeit einer Nitroglycerin-Salbenzubereitung. Arzneimittel-Forschung 30: 320–324, 1980

    PubMed  CAS  Google Scholar 

  • McAllister A, Mosberg H, Settlage JA, Steiner JA. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur, and one ointment formulation, Nitrobid. British Journal of Clinical Pharmacology 21: 365–369, 1986

    Article  PubMed  CAS  Google Scholar 

  • McNiff EF, Yacobi A, Young-Chang FM, Golden LH, Goldfarb A, et al. Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. Journal of Pharmaceutical Sciences 70: 1054–1058, 1981

    Article  PubMed  CAS  Google Scholar 

  • Müller P, Imhof PR, Burkart F, Chu L-C, Gérardin A. Human pharmacological studies of a new transdermal system containing nitroglycerin. European Journal of Clinical Pharmacology 22: 473–480, 1982

    Article  PubMed  Google Scholar 

  • Needleman P. Organic nitrate metabolism. In Elliott et al. (Eds) Annual reviews of pharmacology and toxicology, Vol. 16, pp. 81–93, Annual Reviews Inc., Palo Alto, 1976

    Google Scholar 

  • Noonan PK, Benet LZ. Incomplete and delayed bioavailability of sublingual nitroglycerin. American Journal of Cardiology 55: 184–187, 1985

    Article  PubMed  CAS  Google Scholar 

  • Noonan PK, Benet LZ. The bioavailability of oral nitroglycerin. Journal of Pharmaceutical Sciences 75: 241–243, 1986

    Article  PubMed  CAS  Google Scholar 

  • Noonan PK, Kanfer I, Riegelman S, Benet LZ. Determination of picogram nitroglycerin plasma concentrations using capillary gas chromatography with on-column injection. Journal of Pharmaceutical Sciences 73: 923–927, 1984

    Article  PubMed  CAS  Google Scholar 

  • Noonan PK, Williams RL, Benet LZ. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers. Journal of Pharmacokinetics and Biopharmaceutics 13: 143–157, 1985

    PubMed  CAS  Google Scholar 

  • Olivari M-T, Cohn JN. Cutaneous administration of nitroglycerin: a review. Pharmacotherapy 3: 149–157, 1983

    PubMed  CAS  Google Scholar 

  • Packer M, Medina N, Yushak M, Lee WH. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure. American Journal of Cardiology 57: 260–267, 1986

    Article  PubMed  CAS  Google Scholar 

  • Parker JO, Fung H-L. Transdermal nitroglycerin in angina pectoris. American Journal of Cardiology 54: 471–476, 1984

    Article  PubMed  CAS  Google Scholar 

  • Rey E, Daoud El-Assaf H, Richard MO, Weber S, Bourdon A, et al. Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects. European Journal of Clinical Pharmacology 25: 779–782, 1983

    Article  PubMed  CAS  Google Scholar 

  • Roberts MS, Cossum PA, Galbraith AJ, Boyd GW. The availability of nitroglycerin from parenteral solutions. Journal of Pharmacy and Pharmacology 32: 237–244, 1980

    Article  PubMed  CAS  Google Scholar 

  • Rosseel MT, Bogaert MG. GIC determination of nitroglycerin and isosorbide dinitrate in human plasma. Journal of Pharmaceutical Sciences 62: 754–758, 1973

    Article  PubMed  CAS  Google Scholar 

  • Sanders SW, Michaelis K, Maurette JM, Jaeger H. Relative bioavailability of two spray formulations of nitroglycerin. Journal of Pharmaceutical Sciences 75: 244–246, 1986

    Article  PubMed  CAS  Google Scholar 

  • Schaber DE, Uden DL, McCoy HG. Nitroglycerin adsorption to a combination polyvinyl chloride, polyethylene intravenous administration set. Drug Intelligence and Clinical Pharmacy 19: 572–575, 1985

    PubMed  CAS  Google Scholar 

  • Scheidt SS. Scientific and clinical experience with transdermal nitroglycerin. Proceedings of a symposium, November 21–22, 1985. American Heart Journal 112: 197–248, 1986

    Article  Google Scholar 

  • Settlage JA, Gielsdorf W, Jaeger H. Femtogram level quantitative determination of nitroglycerin and metabolites in human plasma by GC-MS negative ion chemical ionization, single ion monitoring. Journal of High Resolution Chromatography and Chromatography Communications 6: 68–71, 1983

    Article  CAS  Google Scholar 

  • Shaw JE. Transdermal nitroglycerin systems. Vascular Medicine 2: 78–84, 1984

    Google Scholar 

  • Sioufl A, Pommier F. Quantitative determination of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. Journal of Chromatography 339: 117–126, 1985

    Article  Google Scholar 

  • Spanggord RJ, Keck RG. Application of high-pressure liquid chromatography and thermal energy analyzer to analysis of trinitroglycerin and its metabolites in blood. Journal of Pharmaceutical Sciences 69: 444–446, 1980

    Article  PubMed  CAS  Google Scholar 

  • Sved S, McLean WM, McGilveray IJ. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans. Journal of Pharmaceutical Sciences 70: 1368–1369, 1981

    Article  PubMed  CAS  Google Scholar 

  • Wagenknecht DM, Baaske DM, Alam AS, Carter JE, Shah J. Stability of nitroglycerin solutions in polyolefin and glass containers. American Journal of Hospital Pharmacy 41: 1807–1811, 1984

    PubMed  CAS  Google Scholar 

  • Weber S, Rey E, Pipeau C, Lutfalla G, Richard M-O, et al. Influence of aspirin on the hemodynamic effects of sublingual nitroglycerin. Journal of Cardiovascular Pharmacology 5: 874–877, 1983

    Article  PubMed  CAS  Google Scholar 

  • Wei JY, Reid PR. Quantitative determination of trinitroglycerin in human plasma. Circulation 59: 588–592, 1979

    Article  PubMed  CAS  Google Scholar 

  • Windorfer A. Nitroglycerin blood level after buccal and oral application of synchron nitroglycerin. In Bussmann et al. (Eds) Controlled release nitroglycerin in buccal and oral form, Advances in pharmacotherapy, Vol. 1, pp. 44–48, Karger, Basel, 1982

    Google Scholar 

  • Wolff M, Cordes G, Luckow V. In vitro and in vivo-release of nitroglycerin from a new transdermal therapeutic system. Pharmaceutical Research: 23–29, 1985

    Google Scholar 

  • Woodward AJ, Lewis PA, Aylward M, Rudman R, Maddock J. Determination of nitroglycerin and its dinitrate metabolites in human plasma by high-performance liquid chromatography with thermal energy analyzer detection. Journal of Pharmaceutical Sciences 73: 1838–1840, 1984

    Article  PubMed  CAS  Google Scholar 

  • Yacobi A, Amann AH, Baaske DM. Pharmaceutical considerations of nitroglycerin. Drug Intelligence and Clinical Pharmacy 17: 255–263, 1983

    PubMed  CAS  Google Scholar 

  • Yu WC, Goff EU. Determination of vasodilators and their metabolites in plasma by liquid chromatography with a nitrosylspecific detector. Analytical Chemistry 55: 29–32, 1983

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heymans Institute of Pharmacology, University of Gent Medical School, Gent, Belgium

    M. G. Bogaert

Authors
  1. M. G. Bogaert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bogaert, M.G. Clinical Pharmacokinetics of Glyceryl Trinitrate Following the Use of Systemic and Topical Preparations. Clin-Pharmacokinet 12, 1–11 (1987). https://doi.org/10.2165/00003088-198712010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198712010-00001

Keywords

Search

Navigation